[1]
|
B. S. McEwen, “Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain,” Physiological Reviews, Vol. 87, No. 3, 2007, pp. 873-904.
doi:10.1152/physrev.00041.2006
|
[2]
|
R. Cools, K. Nakamura and N. D. Daw, “Serotonin and Dopamine: Unifying Affective, Activational, and Decision Functions,” Neuropsychopharmacology, Vol. 36, No. 1, 2011, pp. 98-113. doi:10.1038/npp.2010.121
|
[3]
|
W. C. Drevets, J. L. Price and M. L. Furey, “Brain Structural and Functional Abnormalities in Mood Disorders: Implications for Neurocircuitry Models of Depression,” Brain Structure & Function, Vol. 213, No. 1-2, 2008, pp 93-118. doi:10.1007/s00429-008-0189-x
|
[4]
|
A. O. Mechan, A. Fowler, N. Seifert, H. Rieger, T. Wohrle, S. Etheve, A. Wyss, G. Schuler, B. Colletto, C. Kilpert, J. Aston, J. M. Elliott, R. Goralczyk and M. H. Mohajeri, “Monoamine Reuptake Inhibition and Mood-Enhancing Potential of a Specified Oregano Extract,” British Journal of Nutrition, Vol. 105, No. 8, 2011, pp. 1150-1163. doi:10.1017/S0007114510004940
|
[5]
|
K. Blum, T. J. Chen, S. Morse, J. Giordano, A. L. Chen, J. Thompson, C. Allen, A. Smolen, J. Lubar, E. Stice, B. W. Downs, R. L. Waite, M. A. Madigan, M. Kerner, F. Fornari and E. R. Braverman, “Overcoming qEEG Abnormalities and Re-ward Gene Deficits during Protracted Abstinence in Male Psychostimulant and Polydrug Abusers Utilizing Putative Dopamine D Agonist Therapy: Part 2,” Postgraduate Medicine, Vol. 122, No. 6, 2010, pp. 214- 226. doi:10.3810/pgm.2010.11.2237
|
[6]
|
M. J. Jutras and E. A. Buffalo, “Synchronous Neural Activity and Memory Formation,” Current Opinion in Neurobiology, Vol. 20, No. 2, 2010, pp. 150-155.
doi:10.1016/j.conb.2010.02.006
|
[7]
|
K. Kitaoka, A. Hattori, S. Chikahisa, K. Miyamoto, Y. Nakaya and H. Sei, “Vitamin A Deficiency Induces a Decrease in EEG Delta Power during Sleep in Mice,” Brain Research, Vol. 1150, 2007, pp. 121-130.
doi:10.1016/j.brainres.2007.02.077
|
[8]
|
M. Moazami-Goudarzi, J. Sarnthein, L. Michels, R. Moukhtieva and J. Jeanmonod, “Enhanced Frontal Low and High Frequency Power and Synchronization in the Resting EEG of Parkinsonian Patients,” Neuroimage, Vol. 41, No. 3, 2008, pp. 985-997.
doi:10.1016/j.neuroimage.2008.03.032
|
[9]
|
W. Dimpfel, A. Kler, E. Kriesl, R. Lehnfeld and I. K. Keplinger-Dimpfel, “Source Density Analysis of the Human EEG after Ingestion of a Drink Containing Decaffeinated Extract of Green Tea Enriched with L-Theanine and Theogallin,” Nutritional Neuroscience, Vol. 10, No. 3-4, 2007, pp.169-180. doi:10.1080/03093640701580610
|
[10]
|
W. Dimpfel, “Preclinical Data Base of Pharmaco-Specific Rat EEG Fingerprints (Tele-Stereo-EEG),” European Journal of Medical Research, Vol. 8, No. 5, 2003, pp. 199- 207.
|
[11]
|
A. Czubak, E. Nowakowska, K. Burda, K. Kus and J. Metelska, “Cognitive Effects of GABAergic Anti-epileptic Drugs,” Arzneimittelforschung, Vol. 60, No. 1, 2010, pp. 1-11. doi:10.1055/s-0031-1296242
|
[12]
|
A. G. Malykh and M. R. Sadaie, “Piracetam and Piracetam-Like Drugs: from Basic Science to Novel Clinical Applications to CNS Disorders,” Drugs, Vol. 70, No. 3, 2010, pp. 287-312.
doi:10.2165/11319230-000000000-00000
|
[13]
|
W. Dimpfel, “Pharmacological Modulation of Cholinergic Brain Activity and Its Reflection in Special EEG Frequency Ranges from Various Brain Areas in the Freely Moving Rat (Tele-Stereo-EEG),” European Neuropsy-chopharmacology, Vol. 15, No. 6, 2005, pp. 673-682.
doi:10.1016/j.euroneuro.2005.03.006
|
[14]
|
W. Dimpfel and F. Schober, “Norepinephrine, EEG Theta Waves and Sedation,” Pharmacology, Vol. 1, 2001, pp. 89-97.
|
[15]
|
W. Dimpfel, “Pharmacological Modulation of Dopaminergic Brain Activity and Its Reflection in Spectral Frequencies of the Rat Electropharmacogram,” Neuropsychobiology, Vol. 58, No. 3-4, 2008, pp. 178-186.
doi:10.1159/000191124
|
[16]
|
W. Dimpfel, M. Spuler, R. Koch and W. Schatton, “Radioelectroencephalographic Comparison of Memantine with Receptor-Specific Drugs Acting on Dopaminergic Transmission in Freely Moving Rats,” Neuropsychobiology, Vol. 18, No. 18, 1987, pp. 212-218.
doi:10.1159/000118420
|
[17]
|
S. Ortigue, N. Patel and F. Bianchi-Demicheli, “New Electroencephalogram (EEG) Neuroimaging Methods of Analyzing Brain Activity Applicable to the Study of Human Sexual Response,” The Journal of Sexual Medicine, Vol. 6, No. 7, 2009, pp. 1830-1845.
doi:10.1111/j.1743-6109.2009.01271.x
|
[18]
|
F. Pulver-muller, Y. Shtyrov and O. Hauk, “Understanding in an Instant: Neurophysiological Evidence for Mechanistic Language Circuits in the Brain,” Brain and Language, Vol. 110, No. 2, 2009, pp. 81-94.
doi:10.1016/j.bandl.2008.12.001
|
[19]
|
J. M. Schoffelen and J. Gross, “Source Connectivity Analysis with MEG and EEG,” Human Brain Mapping, Vol. 30, No. 6, 2009, pp.1857-1865. doi:10.1002/hbm.20745
|
[20]
|
W. Dimpfel, M. Spuler and H. O. Borbe, “Monitoring of the Effects of Antidepressant Drugs in the Freely Moving Rat by Radioelectroencephalography (Tele-Stereo-EEG),” Neurop-sychobiology, Vol. 19, No. 2, 1988, pp. 116-120.
doi:10.1159/000118445
|
[21]
|
G. S. Ruigt, S. Engelen, A. Gerrits and F. Verbon, “Computer-Based Prediction of Psychotropic Drug Classes Based on a Discriminant Analysis of Drug Effects on Rat Sleep,” Neuropsychobiology, Vol. 28, No. 3, 1993, pp. 138-153. doi:10.1159/000119016
|
[22]
|
W. Dimpfel, “Rat Electropharmacograms of the Flavonoids Rutin and Quercetin in Comparison to Those of Moclobemide and Clinically Used Reference Drugs Suggest Antidepressive and/or Neuroprotective Action,” Phytomedicine, Vol. 16, No. 4, 2009, pp. 287-294.
doi:10.1016/j.phymed.2009.02.005
|
[23]
|
W. Dimpfel, M. Spuler and H. G. Menge, “Effects of the Antiparkinson Drug Budipine on EEG Activity in Unrestrained Rats,” Arzneimittelforschung, Vol. 39, No. 5, 1989, pp. 560-563.
|
[24]
|
W. Dimpfel, M. Spuler and D. E. Nichols, “Hallucinogenic and Stimulatory Amphetamine Derivatives: Fingerprinting DOM, DOI, DOB, MDMA, and MBDB by Spectral Analysis of Brain Field Potentials in the Freely moving Rat (Tele-Stereo-EEG),” Psychopharmacology (Berl), Vol. 98, No. 3, 1989, pp. 297-303.
doi:10.1007/BF00451678
|
[25]
|
W. Dimpfel, M. Spuler and B. Nickel, “Radioelectroencephalography (Tele-Stereo-EEG) in the Rat as a Pharmacological Model to Differentiate the Central Action of Flupirtine from That of Opiates, Diazepam and Phenobarbital,” Neuropsychobiology, Vol. 16, No. 2-3, 1986, pp. 163-168. doi:10.1159/000118319
|
[26]
|
G. Paxinos and C. Watson, “The Rat Brain in Stereotactic Coordinates,” Academic Press, New York, 1982.
|
[27]
|
W. Dimpfel, M. Spuler and B. Nickel, “Dose- and Time-Dependent Action of Morphine, Tramadol and Flupirtine as Studied by Radioelectroencephalography in the Freely Behaving Rat,” Neuropsychobiology, Vol. 20, No. 3, 1989, pp. 164-168. doi:10.1159/000118492
|
[28]
|
J. L. Price and W. C. Dre-vets, “Neurocircuitry of Mood Disorders,” Neuropsychopharmacology, Vol. 35, No. 1, 2010, pp. 192-216. doi:10.1038/npp.2009.104
|
[29]
|
K. J. Ressler and H. S. Mayberg, “Targeting Abnormal Neural Circuits in Mood and Anxiety Disorders: From the Laboratory to the Clinic,” Nature Neuroscience, Vol. 10, No. 9, 2007, pp. 1116-1124. doi:10.1038/nn1944
|
[30]
|
L. M. Shin and I. Liberzon, “The Neurocircuitry of Fear, Stress, and Anxiety Disorders” Neuropsychopharmacology, Vol. 35, No. 1, 2010, pp. 169-191.
doi:10.1038/npp.2009.83
|
[31]
|
R. Cools, “Role of Dopamine in the Motivational and Cognitive Control of Behavior,” Neuroscientist, Vol. 14, No. 4, 2008, pp. 381-395. doi:10.1177/1073858408317009
|
[32]
|
M. Pessiglione, B. Seymour, G. Flandin, R. J. Dolan and C. D. Frith, “Dopamine-Dependent Prediction Errors Underpin Reward-Seeking Behaviour in Humans,” Nature, Vol. 442, No. 7106, 2006, pp. 1042-1045.
doi:10.1038/nature05051
|
[33]
|
B. H. Schott, L. Minuzzi, R. M. Krebs, D. Elmenhorst, M. Lang, O. H. Winz, C. I. Seidenbecher, H. H. Coenen, H. J. Heinze, K. Zilles, E. Duzel and A. Bauer, “Mesolimbic Functional Magnetic Resonance Imaging Activations dur- ing Reward Anticipation Correlate with Reward-Related Ventral Striatal Dopamine Release,” Journal of Neuroscience, Vol. 28, No. 28, 2008, pp. 14311-14319.
doi:10.1523/JNEUROSCI.2058-08.2008
|
[34]
|
W. Dimp-fel and J. A. Hoffmann, “Electropharmacograms of Rasagiline, Its Metabolite Aminoindan and Selegiline in the Freely Moving Rat,” Neuropsychobiology, Vol. 62, No. 4, 2010, pp. 213-220. doi:10.1159/000319947
|